ZoomMed Announces the Grant of Options


MONTREAL, QUEBEC--(Marketwired - Jan. 19, 2015) - ZoomMed inc. (TSX VENTURE:ZMD) announces that during a Board of directors held on January 16, 2015, the Board agreed to grant 4,900,000 stock options to its directors and officers and 2,700,000 stock options to its employees and consultants, taking effect on January 19, 2015.

Each of these options allows its holder to purchase one common share of ZoomMed at a price of $0.05 for a five (5) year period following their issuance, subject to the provisions of the stock option plan of ZoomMed and TSX Venture Exchange policies.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements made in this news release that are not historical facts are "forward-looking statements" and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these "forward-looking" statements.

Contact Information:

ZoomMed
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, Ext 228
info@zoommed.com
www.zoommed.com